Report Detail
Global Amebiasis Market Growth 2019-2024
- RnM2774216 |
- 17 January, 2019 |
- Global |
- 167 Pages |
- LPI(LP Information) |
- Pharma & Healthcare
Amebiasis is an infection of the intestine caused by a parasite Entamoeba Histolytica. Symptoms of this disease include loose stool, abdominal cramping, and stomach pain.
According to this study, over the next five years the Amebiasis market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2024, from US$ xx million in 2017. In particular, this report presents the global market share (sales and revenue) of key companies in Amebiasis business, shared in Chapter 3.
This report presents a comprehensive overview, market shares, and growth opportunities of Amebiasis market by product type, application, key manufacturers and key regions and countries.
This study considers the Amebiasis value and volume generated from the sales of the following segments:
Segmentation by product type: breakdown data from 2013 to 2018, in Section 2.3; and forecast to 2024 in section 11.7.
Metronidazole
Paromomycin
Tinidazole
Other
Segmentation by application: breakdown data from 2013 to 2018, in Section 2.4; and forecast to 2024 in section 11.8.
Hospital
Pharmacy
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Spain
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
Dr. Reddy’s Laboratories
Mission Pharmacal
Aceto Corporation
Mylan Pharmaceuticals
Impax Laboratories
Pfizer
Sanofi
Lupin Pharmaceuticals
Glenmark Pharmaceuticals
Sun Pharmaceutical
Heritage Pharmaceuticals
In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.
Research objectives
To study and analyze the global Amebiasis consumption (value & volume) by key regions/countries, product type and application, history data from 2013 to 2017, and forecast to 2024.
To understand the structure of Amebiasis market by identifying its various subsegments.
Focuses on the key global Amebiasis manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Amebiasis with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the consumption of Amebiasis submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.
Table of Contents
2018-2023 Global Amebiasis Consumption Market Report
1 Scope of the Report
- 1.1 Market Introduction
- 1.2 Research Objectives
- 1.3 Years Considered
- 1.4 Market Research Methodology
- 1.5 Economic Indicators
- 1.6 Currency Considered
2 Executive Summary
- 2.1 World Market Overview
- 2.1.1 Global Amebiasis Consumption 2013-2023
- 2.1.2 Amebiasis Consumption CAGR by Region
- 2.2 Amebiasis Segment by Type
- 2.2.1 Metronidazole
- 2.2.2 Paromomycin
- 2.2.3 Tinidazole
- 2.2.4 Other
- 2.3 Amebiasis Consumption by Type
- 2.3.1 Global Amebiasis Consumption Market Share by Type (2013-2018)
- 2.3.2 Global Amebiasis Revenue and Market Share by Type (2013-2018)
- 2.3.3 Global Amebiasis Sale Price by Type (2013-2018)
- 2.4 Amebiasis Segment by Application
- 2.4.1 Hospital
- 2.4.2 Pharmacy
- 2.5 Amebiasis Consumption by Application
- 2.5.1 Global Amebiasis Consumption Market Share by Application (2013-2018)
- 2.5.2 Global Amebiasis Value and Market Share by Application (2013-2018)
- 2.5.3 Global Amebiasis Sale Price by Application (2013-2018)
3 Global Amebiasis by Players
- 3.1 Global Amebiasis Sales Market Share by Players
- 3.1.1 Global Amebiasis Sales by Players (2016-2018)
- 3.1.2 Global Amebiasis Sales Market Share by Players (2016-2018)
- 3.2 Global Amebiasis Revenue Market Share by Players
- 3.2.1 Global Amebiasis Revenue by Players (2016-2018)
- 3.2.2 Global Amebiasis Revenue Market Share by Players (2016-2018)
- 3.3 Global Amebiasis Sale Price by Players
- 3.4 Global Amebiasis Manufacturing Base Distribution, Sales Area, Product Types by Players
- 3.4.1 Global Amebiasis Manufacturing Base Distribution and Sales Area by Players
- 3.4.2 Players Amebiasis Products Offered
- 3.5 Market Concentration Rate Analysis
- 3.5.1 Competition Landscape Analysis
- 3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2016-2018)
- 3.6 New Products and Potential Entrants
- 3.7 Mergers & Acquisitions, Expansion
4 Amebiasis by Regions
- 4.1 Amebiasis by Regions
- 4.1.1 Global Amebiasis Consumption by Regions
- 4.1.2 Global Amebiasis Value by Regions
- 4.2 Americas Amebiasis Consumption Growth
- 4.3 APAC Amebiasis Consumption Growth
- 4.4 Europe Amebiasis Consumption Growth
- 4.5 Middle East & Africa Amebiasis Consumption Growth
5 Americas
- 5.1 Americas Amebiasis Consumption by Countries
- 5.1.1 Americas Amebiasis Consumption by Countries (2013-2018)
- 5.1.2 Americas Amebiasis Value by Countries (2013-2018)
- 5.2 Americas Amebiasis Consumption by Type
- 5.3 Americas Amebiasis Consumption by Application
- 5.4 United States
- 5.5 Canada
- 5.6 Mexico
- 5.7 Key Economic Indicators of Few Americas Countries
6 APAC
- 6.1 APAC Amebiasis Consumption by Countries
- 6.1.1 APAC Amebiasis Consumption by Countries (2013-2018)
- 6.1.2 APAC Amebiasis Value by Countries (2013-2018)
- 6.2 APAC Amebiasis Consumption by Type
- 6.3 APAC Amebiasis Consumption by Application
- 6.4 China
- 6.5 Japan
- 6.6 Korea
- 6.7 Southeast Asia
- 6.8 India
- 6.9 Australia
- 6.10 Key Economic Indicators of Few APAC Countries
7 Europe
- 7.1 Europe Amebiasis by Countries
- 7.1.1 Europe Amebiasis Consumption by Countries (2013-2018)
- 7.1.2 Europe Amebiasis Value by Countries (2013-2018)
- 7.2 Europe Amebiasis Consumption by Type
- 7.3 Europe Amebiasis Consumption by Application
- 7.4 Germany
- 7.5 France
- 7.6 UK
- 7.7 Italy
- 7.8 Russia
- 7.9 Spain
- 7.10 Key Economic Indicators of Few Europe Countries
8 Middle East & Africa
- 8.1 Middle East & Africa Amebiasis by Countries
- 8.1.1 Middle East & Africa Amebiasis Consumption by Countries (2013-2018)
- 8.1.2 Middle East & Africa Amebiasis Value by Countries (2013-2018)
- 8.2 Middle East & Africa Amebiasis Consumption by Type
- 8.3 Middle East & Africa Amebiasis Consumption by Application
- 8.4 Egypt
- 8.5 South Africa
- 8.6 Israel
- 8.7 Turkey
- 8.8 GCC Countries
9 Market Drivers, Challenges and Trends
- 9.1 Market Drivers and Impact
- 9.1.1 Growing Demand from Key Regions
- 9.1.2 Growing Demand from Key Applications and Potential Industries
- 9.2 Market Challenges and Impact
- 9.3 Market Trends
10 Marketing, Distributors and Customer
- 10.1 Sales Channel
- 10.1.1 Direct Marketing
- 10.1.2 Indirect Marketing
- 10.2 Amebiasis Distributors
- 10.3 Amebiasis Customer
11 Global Amebiasis Market Forecast
- 11.1 Global Amebiasis Consumption Forecast (2018-2023)
- 11.2 Global Amebiasis Forecast by Regions
- 11.2.1 Global Amebiasis Forecast by Regions (2018-2023)
- 11.2.2 Global Amebiasis Value Forecast by Regions (2018-2023)
- 11.2.3 Americas Consumption Forecast
- 11.2.4 APAC Consumption Forecast
- 11.2.5 Europe Consumption Forecast
- 11.2.6 Middle East & Africa Consumption Forecast
- 11.3 Americas Forecast by Countries
- 11.3.1 United States Market Forecast
- 11.3.2 Canada Market Forecast
- 11.3.3 Mexico Market Forecast
- 11.3.4 Brazil Market Forecast
- 11.4 APAC Forecast by Countries
- 11.4.1 China Market Forecast
- 11.4.2 Japan Market Forecast
- 11.4.3 Korea Market Forecast
- 11.4.4 Southeast Asia Market Forecast
- 11.4.5 India Market Forecast
- 11.4.6 Australia Market Forecast
- 11.5 Europe Forecast by Countries
- 11.5.1 Germany Market Forecast
- 11.5.2 France Market Forecast
- 11.5.3 UK Market Forecast
- 11.5.4 Italy Market Forecast
- 11.5.5 Russia Market Forecast
- 11.5.6 Spain Market Forecast
- 11.6 Middle East & Africa Forecast by Countries
- 11.6.1 Egypt Market Forecast
- 11.6.2 South Africa Market Forecast
- 11.6.3 Israel Market Forecast
- 11.6.4 Turkey Market Forecast
- 11.6.5 GCC Countries Market Forecast
- 11.7 Global Amebiasis Forecast by Type
- 11.8 Global Amebiasis Forecast by Application
12 Key Players Analysis
- 12.1 Dr. Reddy’s Laboratories
- 12.1.1 Company Details
- 12.1.2 Amebiasis Product Offered
- 12.1.3 Dr. Reddy’s Laboratories Amebiasis Sales, Revenue, Price and Gross Margin (2016-2018)
- 12.1.4 Main Business Overview
- 12.1.5 Dr. Reddy’s Laboratories News
- 12.2 Mission Pharmacal
- 12.2.1 Company Details
- 12.2.2 Amebiasis Product Offered
- 12.2.3 Mission Pharmacal Amebiasis Sales, Revenue, Price and Gross Margin (2016-2018)
- 12.2.4 Main Business Overview
- 12.2.5 Mission Pharmacal News
- 12.3 Aceto Corporation
- 12.3.1 Company Details
- 12.3.2 Amebiasis Product Offered
- 12.3.3 Aceto Corporation Amebiasis Sales, Revenue, Price and Gross Margin (2016-2018)
- 12.3.4 Main Business Overview
- 12.3.5 Aceto Corporation News
- 12.4 Mylan Pharmaceuticals
- 12.4.1 Company Details
- 12.4.2 Amebiasis Product Offered
- 12.4.3 Mylan Pharmaceuticals Amebiasis Sales, Revenue, Price and Gross Margin (2016-2018)
- 12.4.4 Main Business Overview
- 12.4.5 Mylan Pharmaceuticals News
- 12.5 Impax Laboratories
- 12.5.1 Company Details
- 12.5.2 Amebiasis Product Offered
- 12.5.3 Impax Laboratories Amebiasis Sales, Revenue, Price and Gross Margin (2016-2018)
- 12.5.4 Main Business Overview
- 12.5.5 Impax Laboratories News
- 12.6 Pfizer
- 12.6.1 Company Details
- 12.6.2 Amebiasis Product Offered
- 12.6.3 Pfizer Amebiasis Sales, Revenue, Price and Gross Margin (2016-2018)
- 12.6.4 Main Business Overview
- 12.6.5 Pfizer News
- 12.7 Sanofi
- 12.7.1 Company Details
- 12.7.2 Amebiasis Product Offered
- 12.7.3 Sanofi Amebiasis Sales, Revenue, Price and Gross Margin (2016-2018)
- 12.7.4 Main Business Overview
- 12.7.5 Sanofi News
- 12.8 Lupin Pharmaceuticals
- 12.8.1 Company Details
- 12.8.2 Amebiasis Product Offered
- 12.8.3 Lupin Pharmaceuticals Amebiasis Sales, Revenue, Price and Gross Margin (2016-2018)
- 12.8.4 Main Business Overview
- 12.8.5 Lupin Pharmaceuticals News
- 12.9 Glenmark Pharmaceuticals
- 12.9.1 Company Details
- 12.9.2 Amebiasis Product Offered
- 12.9.3 Glenmark Pharmaceuticals Amebiasis Sales, Revenue, Price and Gross Margin (2016-2018)
- 12.9.4 Main Business Overview
- 12.9.5 Glenmark Pharmaceuticals News
- 12.10 Sun Pharmaceutical
- 12.10.1 Company Details
- 12.10.2 Amebiasis Product Offered
- 12.10.3 Sun Pharmaceutical Amebiasis Sales, Revenue, Price and Gross Margin (2016-2018)
- 12.10.4 Main Business Overview
- 12.10.5 Sun Pharmaceutical News
- 12.11 Heritage Pharmaceuticals
13 Research Findings and Conclusion
Summary:
Get latest Market Research Reports on Amebiasis. Industry analysis & Market Report on Amebiasis is a syndicated market report, published as Global Amebiasis Market Growth 2019-2024. It is complete Research Study and Industry Analysis of Amebiasis market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
